NICE reveals latest impartial information about innovative devices and diagnostics
An electronic brachytherapy system for early-stage breast cancer, and an in vitro diagnostic molecular assay system for colon cancer staging are the subjects of two newly-published Medtech Innovation Briefings from the National Institute of Health and Care Excellence (NICE).
The documents are commissioned by NHS England and produced in support of the NHS Five Year Forward View as one of a number of steps to accelerate innovation in new treatments and diagnostics.
It is hoped this impartial information about innovative devices and diagnostics will help NHS and social care professionals and buyers and commissioners of services with their local decision-making.
The briefings include a review of relevant published evidence and the likely costs of using the technology, but they are not NICE guidance and do not make any recommendations on the value of using the technologies. Whether or not to use the products described is entirely the choice of local staff. However, they will help avoid the need for organisations to produce similar information, so saving staff time, effort and resources.
The latest Medtech Innovation Briefings to be published are:
